WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Cerrar esta carpetaAntifugal drugs
Ver el documentoAmphotericin B
Ver el documentoBenzoic acid + salicylic acid (Whitfield’s ointment)
Ver el documentoClotrimazole
Ver el documentoEconazole
Ver el documentoFluconazole
Ver el documentoFlucytosine
Ver el documentoGriseofulvin
Ver el documentoItraconazole
Ver el documentoKetoconazole
Ver el documentoMiconazole
Ver el documentoNystatin
Ver el documentoPotassium iodide
Ver el documentoSelenium sulfide
Ver el documentoSodium thiosulfate
Ver el documentoTerbinafine
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Selenium sulfide

Detergent-based suspension, 2.5%

General information

Selenium sulfide is an anti-infective agent with antibacterial and mild anti-fungal activity.

Clinical information

Uses

Treatment of pityriasis (tinea) versicolor and seborrhoeic dermatitis.

Dosage and administration

All doses are suitable for adults and children over 2 years.

Pityriasis versicolor:

A thin coating of undiluted suspension should be applied at bedtime to the trunk, groin, upper limbs and axillae and rinsed off after 5-15 minutes. Treatment should be repeated after 3 and 6 days.

Seborrhoeic dermatitis:

5-10 ml of the suspension is massaged into the wet scalp and left for 2-3 minutes before rinsing off. Treatment should be repeated twice weekly for 2 weeks.

Contraindications

• Known hypersensitivity to selenium sulfide.
• Age under 2 years.

Precautions

Treatment should be discontinued if cutaneous sensitization occurs.

Selenium sulfide suspension should not be applied to damaged skin because of the risk of systemic toxicity. Contact with the eyes should also be avoided.

Use in pregnancy

Safe use in pregnancy has not been established. Treatment is best deferred until after delivery.

Adverse effects

Prolonged contact with the skin may cause local irritation.

Topical application to damaged skin can cause systemic toxicity, characterized by tremors, weakness, lethargy, pain in the lower abdomen and occasional vomiting. These symptoms usually resolve within 10 days of discontinuing treatment.

Storage

Selenium sulfide suspension should be stored in tightly closed containers in a cool place.

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 20 marzo 2014